Characteristics of Immune Checkpoint Inhibitors Trials Associated With Inclusion of Patients With HIV: A Systematic Review and Meta-analysis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 31702796.
- Also identified by DOI 10.1001/jamanetworkopen.2019.14816 and PMC identifier 6902798.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This systematic review and meta-analysis examines factors associated with inclusion of patients with HIV in clinical trials of immune checkpoint inhibitors.
Medical subject headings
- B7-H1 Antigen
- CTLA-4 Antigen
- Cell Cycle Checkpoints
- HIV Infections
- Programmed Cell Death 1 Receptor